MARKET

ADIL

ADIL

Adial Pharmaceuticals Inc
NASDAQ
1.330
-0.070
-5.00%
After Hours: 1.370 +0.04 +3.01% 19:48 03/28 EDT
OPEN
1.420
PREV CLOSE
1.400
HIGH
1.430
LOW
1.310
VOLUME
84.71K
TURNOVER
0
52 WEEK HIGH
14.00
52 WEEK LOW
0.7650
MARKET CAP
2.21M
P/E (TTM)
-0.2371
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ADIL last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at ADIL last week (0311-0315)?
Weekly Report · 03/18 10:38
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Cardlytics, Inc. Shares jumped 36.6% in pre-market trading after the company reported better-than-expected fourth-quarter earnings. Fisker shares dipped around 52% on Thursday following a report suggesting the company is preparing for a possible bankruptcy filing. Madrigal Pharmaceuticals, Inc.: Shares rose 26.9% after FDA approval of Rezdiffra.
Benzinga · 03/15 12:13
Weekly Report: what happened at ADIL last week (0304-0308)?
Weekly Report · 03/11 10:36
BYSI, PHUN and DTSS among pre-market losers
On the Move BYSI, PHUN and DTSS among pre-market losers. Entravision Communications Corp. (EVC) -48% after Q4 earnings release. Thor Industries (THO) and Nordstrom (JWN) also among the losers.
Seeking Alpha · 03/06 13:24
MINM, RMCO and GRFS among pre-market losers
On the Move MINM, RMCO and GRFS among pre-market losers. BioVie (BIVI) -46% on prices $21M equity offering. Astra Space (ASTR) and Minim (MINM) among the day's losers.
Seeking Alpha · 03/04 13:17
12 Health Care Stocks Moving In Monday's Pre-Market Session
Quoin Pharmaceuticals (NASDAQ:QNRX) stock rose 71.1% to $4.74 during Monday's pre-market session. The company's market cap rose to $1.6 billion. Helius Medical Tech shares increased by 55.04% and Renalytix stock rose 43.26% during the same period.
Benzinga · 03/04 13:09
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Shares of BioVie Inc. Fell sharply in today’s pre-market trading after the company reported pricing of public offering. Ainos, Inc. Gained 112.3% to $2.23 in pre- market trading. Super Micro Computer will join the S&P 500 Index, effective March 18.
Benzinga · 03/04 13:04
More
About ADIL
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. The Company’s drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is used for the treatment of AUD in subjects with certain target genotypes, which were identified using its companion diagnostic genetic test. AD04 is a genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for the treatment of AUD. The Company’s AD04 also has the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.

Webull offers Adial Pharmaceuticals Inc stock information, including NASDAQ: ADIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADIL stock methods without spending real money on the virtual paper trading platform.